Company Overview

The Cannabist Company Holdings Inc. is a U.S.-based cannabis company focused on the cultivation, processing, and retail distribution of regulated cannabis products. The company operates within the cannabis cultivation, manufacturing, and retail dispensary segments, primarily serving medical cannabis patients and, in select jurisdictions, adult-use consumers. Its core revenue is generated through company-owned retail dispensaries and the sale of branded cannabis products produced in its cultivation and processing facilities.

Formerly known as Columbia Care Inc., the company rebranded to The Cannabist Company in 2023 to align its corporate identity with its flagship retail brand. Founded in 2012, the company expanded rapidly through organic growth and acquisitions, becoming one of the larger U.S. multi-state cannabis operators. Its strategy historically emphasized vertically integrated operations in limited-license states, which provided regulatory barriers to entry and pricing power. The company filed for Chapter 11 bankruptcy protection in 2023 and continues to operate while restructuring its balance sheet and asset portfolio.

Business Operations

The company’s operations are organized around vertically integrated cannabis activities, including cultivation, manufacturing, and retail sales. It generates revenue primarily through its Cannabist retail dispensary brand and wholesale distribution of its proprietary product lines, which include flower, edibles, oils, and vape products. The company controls cultivation and processing assets that support its retail footprint, allowing for internal supply and brand consistency.

Operations span multiple U.S. jurisdictions with regulated medical or adult-use cannabis markets. The company owns and operates licensed subsidiaries across several states, with assets held through state-specific operating entities. It has historically engaged in strategic partnerships and acquisitions to enter new markets, though recent restructuring efforts have focused on divesting non-core assets, closing underperforming locations, and renegotiating lease and debt obligations to stabilize cash flow.

Strategic Position & Investments

The Cannabist Company’s current strategic direction is centered on financial restructuring, operational efficiency, and focusing on its strongest markets. Key initiatives include reducing leverage, exiting capital-intensive or low-margin markets, and prioritizing profitability over expansion. The company has publicly stated its intent to streamline operations while preserving core retail and cultivation assets that generate positive operating cash flow.

Historically, growth was driven by acquisitions, including the expansion of Columbia Care into new states and limited-license markets. Post-rebranding, investment activity has shifted away from large-scale acquisitions toward internal optimization and selective asset sales. The company remains exposed to evolving cannabis regulations and continues to monitor federal and state-level policy developments that could materially affect taxation, banking access, and interstate commerce.

Geographic Footprint

The company’s headquarters is located in the United States, and its operations are entirely U.S.-focused. It maintains a multi-state footprint across the Northeast, the Mid-Atlantic, the Midwest, the South, and the Western United States, with varying degrees of vertical integration depending on state regulations.

The Cannabist Company operates in both mature and emerging cannabis markets, with a stronger presence in states that have established medical programs and limited license structures. While the company previously pursued broad geographic expansion, its current footprint reflects a more concentrated operational strategy aligned with its restructuring efforts and regulatory realities.

Leadership & Governance

The company is governed by a board of directors and led by an executive management team with experience in cannabis, healthcare, consumer packaged goods, and restructuring environments. Leadership has emphasized disciplined capital allocation, regulatory compliance, and long-term sustainability in a constrained capital market.

Key executives include:

• David Hart – Chief Executive Officer
• Ben Kovler – Chairman of the Board
• Erick Rodriguez – Chief Financial Officer
• John DeRoos – President
• Michael Abbott – Chief Operating Officer

The leadership team’s stated philosophy centers on stabilizing operations, strengthening governance, and positioning the company to benefit from future regulatory normalization of the U.S. cannabis industry while maintaining compliance with existing state-level frameworks.